112 related articles for article (PubMed ID: 9243329)
1. Modulation of tyrosine kinase activity has multiple actions on insulin release from the pancreatic beta-cell: studies with lavendustin A.
Hisatomi M; Hayakawa T; Hidaka H; Niki I
Jpn J Pharmacol; 1997 Jun; 74(2):203-8. PubMed ID: 9243329
[TBL] [Abstract][Full Text] [Related]
2. Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets.
Jonas JC; Plant TD; Gilon P; Detimary P; Nenquin M; Henquin JC
Br J Pharmacol; 1995 Feb; 114(4):872-80. PubMed ID: 7773549
[TBL] [Abstract][Full Text] [Related]
3. Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion.
Sorenson RL; Brelje TC; Roth C
Endocrinology; 1994 Apr; 134(4):1975-8. PubMed ID: 8137766
[TBL] [Abstract][Full Text] [Related]
4. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats.
Blair HC; Jordan SE; Peterson TG; Barnes S
J Cell Biochem; 1996 Jun; 61(4):629-37. PubMed ID: 8806087
[TBL] [Abstract][Full Text] [Related]
5. Role of tyrosine kinase in insulin release in an insulin secreting cell line (INS-1).
Verspohl EJ; Tollkühn B; Kloss H
Cell Signal; 1995 Jul; 7(5):505-12. PubMed ID: 8562311
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitors inhibit glucose-stimulated insulin secretion.
Jones PM; Persaud SJ
Biochem Soc Trans; 1994 May; 22(2):209S. PubMed ID: 7525376
[No Abstract] [Full Text] [Related]
7. Evidence for a role of protein tyrosine kinases in cell death induced by gp120 in CHP100 neuroblastoma cells.
Russo R; Navarra M; Rotiroti D; Di Renzo G
Toxicol Lett; 2003 Apr; 139(2-3):207-11. PubMed ID: 12628756
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinases play a permissive role in glucose-induced insulin secretion from adult rat islets.
Persaud SJ; Harris TE; Burns CJ; Jones PM
J Mol Endocrinol; 1999 Feb; 22(1):19-28. PubMed ID: 9924176
[TBL] [Abstract][Full Text] [Related]
9. Protein-tyrosine kinases activate while protein-tyrosine phosphatases inhibit L-type calcium channel activity in pituitary GH3 cells.
Cataldi M; Taglialatela M; Guerriero S; Amoroso S; Lombardi G; di Renzo G; Annunziato L
J Biol Chem; 1996 Apr; 271(16):9441-6. PubMed ID: 8621613
[TBL] [Abstract][Full Text] [Related]
10. Role of tyrosine phosphorylation in potassium channel activation. Functional association with prolactin receptor and JAK2 tyrosine kinase.
Prevarskaya NB; Skryma RN; Vacher P; Daniel N; Djiane J; Dufy B
J Biol Chem; 1995 Oct; 270(41):24292-9. PubMed ID: 7592639
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of stretch-induced increase in L-type calcium channel currents by herbimycin A in canine basilar arterial myocytes.
Kimura M; Obara K; Sasase T; Ishikawa T; Tanabe Y; Nakayama K
Br J Pharmacol; 2000 Jun; 130(4):923-31. PubMed ID: 10864901
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase inhibitors suppress N-type and T-type Ca2+ channel currents in NG108-15 cells.
Morikawa H; Fukuda K; Mima H; Shoda T; Kato S; Mori K
Pflugers Arch; 1998 Jun; 436(1):127-32. PubMed ID: 9560456
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation status, cytokine action and protein tyrosine phosphorylation modulate leukotriene biosynthesis in a basophil leukaemia and a mastocytoma cell line.
Hagmann W
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):467-72. PubMed ID: 7513514
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Ca(2+)-activated K+ channel activity by tyrosine kinase inhibitors in vascular smooth muscle cell.
Xiong Z; Burnette E; Cheung DW
Eur J Pharmacol; 1995 Jul; 290(2):117-23. PubMed ID: 8575525
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of protein tyrosine kinase alters the effect of serum basic protein I on triacylglycerols and cholesterol differently in normal and hyperapoB fibroblasts.
Kwiterovich PO; Motevalli M
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1195-203. PubMed ID: 7627714
[TBL] [Abstract][Full Text] [Related]
16. Effects of tyrosine kinase inhibitors on tyrosine phosphorylations and the insulin-like effects in response to human growth hormone in isolated rat adipocytes.
Ridderstråle M; Tornqvist H
Endocrinology; 1996 Nov; 137(11):4650-6. PubMed ID: 8895329
[TBL] [Abstract][Full Text] [Related]
17. Specific attenuation of the pressure-induced contraction of rat cerebral artery by herbimycin A.
Masumoto N; Nakayama K; Oyabe A; Uchino M; Ishii K; Obara K; Tanabe Y
Eur J Pharmacol; 1997 Jul; 330(1):55-63. PubMed ID: 9228414
[TBL] [Abstract][Full Text] [Related]
18. Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells.
Blanco A; Habib A; Levy-Toledano S; Maclouf J
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):419-23. PubMed ID: 8526850
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitors, herbimycin A and lavendustin A, block formation of long-term potentiation in the dentate gyrus in vivo.
Abe K; Saito H
Brain Res; 1993 Sep; 621(1):167-70. PubMed ID: 8221070
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of tyrosine kinase inhibitors on tumor necrosis factor and nitric oxide production by murine macrophages.
Orlicek SL; Meals E; English BK
J Infect Dis; 1996 Sep; 174(3):638-42. PubMed ID: 8769628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
